Oupushifang Pharmaceutical Technology Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Oupushifang Pharmaceutical Technology Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| The Effectiveness and Safety of Two Low-concentration Atropine Sulfate Eye Drops (0.01%/0.02%) for Delaying the Pediatric Myopia Progression (NCT06708156) | Oupushifang Pharmaceutical Technology Co., Ltd. | 2024-06-15 |
Track Oupushifang Pharmaceutical Technology Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.